Author:
Dragowska Wieslawa H.,Ginj Mihaela,Kozlowski Piotr,Yung Andrew,Ruth Thomas J.,Adam Michael J.,Sossi Vesna,Bally Marcel B.,Yapp Donald T. T.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177–182 (1987).
2. Hynes, N. E. & Lane, H. A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5, 341–354 (2005).
3. Arteaga, C. L. et al. Treatment of HER2-positive breast cancer: current status and future perspectives. Nature reviews. Clinical oncology 9, 16–32, 10.1038/nrclinonc.2011.177 (2012).
4. Kern, J. A. et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer research 50, 5184–5187 (1990).
5. Santin, A. D. et al. Overexpression of HER-2/neu in uterine serous papillary cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 8, 1271–1279 (2002).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献